The aim of this study was to examine the longitudinal response for overall and individual symptoms during the treatment of major depressive disorder. Data were pooled from two 9-week trials, which compared duloxetine 60-mg QD (n ΒΌ 251) with placebo (n ΒΌ 261) in the treatment of MDD. Changes from bas
Changes in symptoms of depression during the course of therapy
β Scribed by Adele S. Rabin; Nadine J. Kaslow; Lynn P. Rehm
- Publisher
- Springer US
- Year
- 1984
- Tongue
- English
- Weight
- 437 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0147-5916
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Little is known about the course of depressive symptoms in Parkinson's disease (PD). We studied the course of clinically significant depressive symptoms using data from two clinical trials that followed 413 early, untreated PD subjects for 12 to 18 months. We measured depressive symptom
## Abstract ## Background The study aimed: (1) to describe the 12βmonth course of depressive symptoms among medical inpatients aged 65 +, and (2) to investigate predictors of a more severe course that could be identified easily by nonβpsychiatric staff. ## Methods Patients were recruited at two